Cognitive Behavioral Therapy for Insomnia and Alcohol Abuse (ReTRAIN Trial)

N/A

Recruiting

Research Sponsored by University of Missouri-Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Must not have

Have symptoms requiring immediate clinical attention (e.g., psychosis, suicide plan)

Moderate to severe sleep apnea that is untreated

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to mid-treatment (week 4) to post-treatment (week 6) to 1-, 3-, and 6-month follow-ups

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to see if treating insomnia can help people with alcohol use problems."

Who is the study for?

This trial is for adults under 50 who drink heavily, have been diagnosed with both Insomnia Disorder and Alcohol Use Disorder according to DSM-5 criteria. It's not for those with mania, seizure disorders, severe sleep apnea (unless treated), or those already in treatment for insomnia or alcohol issues.

What is being tested?

The study tests if treating insomnia with Cognitive Behavioral Therapy (CBT-I) can help improve alcohol use problems. Participants will receive CBT-I sessions aimed at improving their sleep patterns.

What are the potential side effects?

CBT-I generally has no physical side effects as it's a non-medical therapy involving talking and behavior change strategies. However, changing sleep habits can sometimes lead to temporary discomfort like fatigue.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I need urgent care for severe mental health symptoms.

Select...

I have untreated sleep apnea that is moderate to severe.

Select...

I am 50 years old or older.

Select...

I am unable to understand and agree to the study's details on my own.

Select...

I do not have mania or a seizure disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to mid-treatment (week 4) to post-treatment (week 6) to 1-, 3-, and 6-month follow-ups

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to mid-treatment (week 4) to post-treatment (week 6) to 1-, 3-, and 6-month follow-ups

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to mid-treatment (week 4) to post-treatment (week 6) to 1-, 3-, and 6-month follow-ups for reporting.